Root Financial Partners’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
Other funds holding SPRY
Root Financial Partners's SPRY Position: Q3 2026 in Review
Root Financial Partners opened a new position in ARS Pharmaceuticals (SPRY) in Q3 2026: 341 shares worth $1.47K. The stake represents ﹤0.01% of the portfolio and ranks #2781 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in SPRY as recently as Q1 2026.
Root Financial Partners first reported a position in SPRY in Q1 2026 and has held it in 2 quarters since. 190 funds tracked by Wall St. Rank hold SPRY as of Q3 2026.
- Root Financial Partners held 341 shares of ARS Pharmaceuticals worth $1.47K as of Q3 2026.
- ARS Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
- ARS Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #2781 holding.
- Root Financial Partners first reported a position in ARS Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- 190 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q3 2026.
Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.